The NfL protein, a neuron-specific element of the neuronal cytoskeleton, has been identified as a biomarker for neuronal damage, with elevated levels in CSF and blood linked to various neurological conditions, including multiple sclerosis, frontotemporal dementia, and Guillain–Barre syndrome26,27. Here, NEFL is linked to multiple sclerosis.